The frequency of calreticulin and mpl gene mutations in bcr-abl and jak2 unmutated chronic myeloproliferative neoplasms and its effect on the outcome

• T. Tiryaki,
• A. DağLar Aday,
• M. Güzel Mastanzade,
• M. ÖZbalak,
• D. Özlük,
• F.Y. Onal Hindilerden,
• M. Yenerel,
• A. Yavuz,
• S. Kalayoğlu Beşışık,
• M. Nalçacı

Affiliations

T. Tiryaki

İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey

A. DağLar Aday

İstanbul University, İstanbul Medical Faculty, Department of Medical Genetics, İstanbul, Turkey

M. Güzel Mastanzade

İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey

M. ÖZbalak

İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey

D. Özlük

İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey

F.Y. Onal Hindilerden

İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey

M. Yenerel

İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey

A. Yavuz

İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey

S. Kalayoğlu Beşışık

İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey; Corresponding author.

M. Nalçacı

İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey